The Effect of Diabetes on the Newborn

Diabetes Clinical Trial

Official title:

Biochemical, Hematologic, and Inflammatory Effects of Diabetes on the Newborn

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00831519
• Other study ID #: JB_6.08_1
• Status: Completed
• Phase: N/A
• First received: January 28, 2009
• Last updated: November 29, 2017
• Start date: January 2009
• Est. completion date: December 2015

Study information

• Verified date: November 2017
• Source: Western Galilee Hospital-Nahariya
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim of this study is to test and compare biochemical, hematological, and inflammatory factors in diabetic and healthy pregnant mothers and in their newborns.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: December 2015
• Est. primary completion date: February 2015
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

• pregnant women

Exclusion Criteria:

Related Conditions & MeSH terms

• Diabetes
• Diabetes Mellitus

Locations

Country	Name	City	State
Israel	Western Galilee Hospital- Nahariya	Nahariya

Sponsors (1)

Lead Sponsor	Collaborator
Western Galilee Hospital-Nahariya

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	oxidative stress	New borns of diabetic mother may have oxidative stress	Immediately after delivery by cesarean section